Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1999-09-27
Original market date: See footnote 1
1978-12-31
Product name:
NOBESINE 75 SUSTAINED RELEASE CAPSULE 75MG
DIN:
00779490 Electronic product monograph is not available
Company:
ROUGIER PHARMA DIVISION OF RATIOPHARM INC
30 Novopharm Court
Toronto
Ontario
Canada
M1B 2K9
Class:
Human
Dosage form(s):
Capsule (Sustained-Release)
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Schedule G (CDSA IV)
American Hospital Formulary Service (AHFS): See footnote 3
28:20.08.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
A08AA03 AMFEPRAMONE
Active ingredient group (AIG) number:See footnote5
0102499001
Active ingredient(s) | Strength |
---|---|
DIETHYLPROPION HYDROCHLORIDE | 75 MG |